Documents | Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy | Guidance | NICE

Documents

A list of downloadable documents created during development.

Expected publication

Equality Impact Assessment (Guidance development) ^{PDF 173.19 KB} 29 April 2016

Final appraisal determination

Final appraisal determination
Final appraisal determination document ^{PDF 446.13 KB} 26 November 2015
Committee papers ^{PDF 1.08 MB} 26 November 2015

Appraisal consultation

Appraisal consultation
Committee papers information
Committee papers ^{PDF 9.3 MB} 15 September 2015
Appraisal consultation document ^{PDF 434.07 KB} 15 September 2015

Final scope

Final scope ^{PDF 95.12 KB} 16 March 2015

Final matrix

Final matrix ^{PDF 34.84 KB} 05 August 2015

NICEs response to comments on the draft scope and provisional matrix

NICEs response to comments on the draft scope and provisional matrix ^{PDF 147.81 KB} 16 March 2015

Equality impact assessment

Equality impact assessment ^{PDF 120.43 KB} 16 March 2015

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): provisional matrix (pre-referral) July 2014

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): provisional matrix (pre-referral) July 2014 ^{PDF 102.16 KB} 06 February 2015

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): draft scope for consultation (pre-referral) July 2014

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): draft scope for consultation (pre-referral) July 2014 ^{PDF 105.37 KB} 06 February 2015